Fairvalue-Calculator Fairvalue-Calculator
EN DE

Koninklijke Philips N.V (PHG) Fair Value & Analysis

Healthcare · US · Market cap $26.0B

Price$26.61
Fair Value$12.54
Upside-52.9%
Quality95/100
Evidence: High Range $9.49 – $20.68

Fair value as of: Jun 24, 2026

✦ Find undervalued quality stocks — 34,000+ analysed Find stocks →

Analysis

Koninklijke Philips N.V (PHG) currently trades at $26.61, while our model-based Fair Value estimate is $12.54 — implying the stock looks roughly 52.9% overvalued today. We read business quality at 95/100 (high quality), in the Healthcare sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium — the entry price still matters most (evidence: high).

About the company

Koninklijke Philips N.V. operates as a health technology company in North America, the Greater China, and internationally. It operates through Diagnosis & Treatment, Connected Care, and Personal Health segments. The company provides diagnostic imaging solutions, includes ultrasound business unit, magnetic resonance imaging, computed tomography, and diagnostic x-ray; Image Guided Therapy, including image guided therapy systems and image guided therapy devices. It also offers monitoring, enterprise informatics, and sleep and respiratory care, as well as personal health. Koninklijke Philips N.V. has strategic alliance with WellSpan Health to advanced imaging and diagnostics technology products and platforms. The company was formerly known as Koninklijke Philips Electronics N.V. and changed its name to Koninklijke Philips N.V. in May 2013. Koninklijke Philips N.V. was founded in 1891 and is headquartered in Amsterdam, the Netherlands.

Open the full interactive analysis →

Similar stocks

Abbott Laboratories, (ABT) -23% Stryker Corporation (S1YK34) -89% Medtronic plc (MDT) -7% Boston Scientific Corporation (B1SX34) -81% Edwards Lifesciences Corporation (EW) -53% Siemens Healthineers AG (SEMHF) +11%

Frequently asked questions

Is Koninklijke Philips N.V (PHG) undervalued?
As of Jun 24, 2026, our model estimates a fair value of $12.54 versus a price of $26.61 — about −53% (overvalued). Model-based estimate, not financial advice.
What is the fair value of PHG?
Our 21-model fair value for Koninklijke Philips N.V is $12.54 (as of Jun 24, 2026), built from audited fundamentals. The current price is $26.61.
What is the quality score of PHG?
Koninklijke Philips N.V has a Quality Score of 95/100, measuring profitability, growth and balance-sheet strength from non-valuation factors.

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.

Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.